192 related articles for article (PubMed ID: 12503213)
41. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.
Ficarra V; Novara G; Martignoni G
Eur Urol; 2009 Nov; 56(5):782-4; discussion 784-5. PubMed ID: 19660853
[No Abstract] [Full Text] [Related]
42. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W
BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
[TBL] [Abstract][Full Text] [Related]
43. Routine frozen-section biopsy from the surgical bed should be performed during nephron-sparing surgery for renal cell carcinoma.
Eroğlu M; Unsal A; Bakirtaş H; Tekdoğan U; Ataoğlu O; Balbay MD
Scand J Urol Nephrol; 2005; 39(3):222-5. PubMed ID: 16118094
[TBL] [Abstract][Full Text] [Related]
44. Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
Crépel M; Isbarn H; Capitanio U; Liberman D; Jeldres C; Sun M; Shariat SF; Widmer H; Arjane P; Graefen M; Montorsi F; Patard JJ; Perrotte P; Karakiewicz PI
Urology; 2009 Oct; 74(4):842-5. PubMed ID: 19628262
[TBL] [Abstract][Full Text] [Related]
45. Preoperative staging of renal cell carcinoma using magnetic resonance imaging: comparison with pathological staging.
Spero M; Brkljacic B; Kolaric B; Marotti M
Clin Imaging; 2010; 34(6):441-7. PubMed ID: 21092873
[TBL] [Abstract][Full Text] [Related]
46. Significance of margin in nephron sparing surgery for renal cell carcinoma of 4 cm or less.
Li QL; Guan HW; Wang FP; Jiang T; Wu HC; Song XS
Chin Med J (Engl); 2008 Sep; 121(17):1662-5. PubMed ID: 19024095
[TBL] [Abstract][Full Text] [Related]
47. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
Svatek RS; Lotan Y; Herman MP; Duchene DA; Sagalowsky AI; Cadeddu JA
J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
[TBL] [Abstract][Full Text] [Related]
48. Prognostic factors and selection for clinical studies of patients with kidney cancer.
Lam JS; Klatte T; Kim HL; Patard JJ; Breda A; Zisman A; Pantuck AJ; Figlin RA
Crit Rev Oncol Hematol; 2008 Mar; 65(3):235-62. PubMed ID: 17931881
[TBL] [Abstract][Full Text] [Related]
49. [Nephron-sparing surgery for localized kidney neoplasms--a report of 25 cases].
Li YH; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Yu SL; Wang H
Ai Zheng; 2006 Jan; 25(1):76-9. PubMed ID: 16405755
[TBL] [Abstract][Full Text] [Related]
50. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
[TBL] [Abstract][Full Text] [Related]
51. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
52. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Orsola I
Urology; 2005 Jan; 65(1):49-54. PubMed ID: 15667862
[TBL] [Abstract][Full Text] [Related]
53. [The role of nephron sparing surgery for renal cancer].
Meyer G; Mullerad M; Nativ O
Harefuah; 2003 Mar; 142(3):208-11, 237. PubMed ID: 12696476
[TBL] [Abstract][Full Text] [Related]
54. Debulking nephrectomy in metastatic renal cancer.
Flanigan RC
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
[TBL] [Abstract][Full Text] [Related]
55. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
[TBL] [Abstract][Full Text] [Related]
56. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
[TBL] [Abstract][Full Text] [Related]
57. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma.
Lohse CM; Cheville JC
Clin Lab Med; 2005 Jun; 25(2):433-64. PubMed ID: 15848745
[TBL] [Abstract][Full Text] [Related]
58. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
59. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
[TBL] [Abstract][Full Text] [Related]
60. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
